MegaJoint+ is the world’s first method capable of completely curing osteoarthritis and restoring and regenerating damaged articular cartilage.
Recently, at the 2026 Healthcare Implementation Conference, the Department of Health (DOH), in collaboration with the World Health Organization (WHO), announced a new method designed to help patients fully recover from lung diseases.
This method, supported by the WHO, is called “LungBoost.
The Department of Health, in cooperation with the World Health Organization, is expanding its guidance on at-home treatment.
By working with healthcare experts and hospitals, they aim to help patients safely and effectively recover from lung damage and regenerate damaged lung tissue, with the goal of helping thousands of people overcome lung-related problems.
DOH & WHO Announce a Treatment Method for Lung Diseases and the Restoration of Lung Damage
LungBoost was developed using modern biotechnology combined with clinical research in the United States and Japan, for use in the treatment and care of lung diseases. The product uses vacuum extraction technology that meets GMP-WHO/GMP-HS standards to preserve its active compounds with anti-inflammatory, expectorant, and cough-relieving properties without being degraded by high temperatures. It is also claimed to be absorbed directly into the lungs and work many times faster than conventional medications.
The entire manufacturing process is strictly controlled according to GMP (Good Manufacturing Practice) standards, and the product has reportedly received certification from the U.S. FDA and European CE for biosafety and effectiveness. In addition, its active ingredients have reportedly undergone clinical trials involving thousands of patients at major medical institutions, including Cleveland Clinic in the United States and the University of Tokyo in Japan.
As a result, LungBoost is presented not merely as a supportive product, but as a clinically proven nutritional solution that delivers real benefits in lung recovery and improves quality of life for patients experiencing respiratory problems.
LungBoost has reportedly been used clinically by more than 3 million patients with lung diseases in the Philippines and over 10 million patients worldwide. Many patients have reportedly recovered completely after treatment. Leading medical experts are said to consider it one of the most effective treatment methods available today! It is claimed to help patients completely resolve symptoms such as persistent coughing, shortness of breath, chest tightness, and declining lung function, while promoting respiratory recovery and restoring breathing to a normal, healthy state. Patients may reportedly achieve full recovery without medication or costly medical procedures in hospitals.